Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15078482rdf:typepubmed:Citationlld:pubmed
pubmed-article:15078482lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:15078482lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15078482lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:15078482lifeskim:mentionsumls-concept:C0023890lld:lifeskim
pubmed-article:15078482lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15078482lifeskim:mentionsumls-concept:C0163305lld:lifeskim
pubmed-article:15078482pubmed:issue2lld:pubmed
pubmed-article:15078482pubmed:dateCreated2004-4-13lld:pubmed
pubmed-article:15078482pubmed:abstractTextNuclear factor kappa B (NF-kappaB) activation, proinflammatory cytokines, and reactive oxygen species have been implicated as mediators of liver injury and fibrogenesis. We have shown recently that pyrrolidine dithiocarbamate (PDTC), an antioxidant and inhibitor of NF-kappaB activation, was protective in a rat model of acute liver failure. The aim of the present study was to examine the efficacy of PDTC in a chronic rat model of thioacetamide (TAA)-induced hepatic fibrosis.lld:pubmed
pubmed-article:15078482pubmed:languageenglld:pubmed
pubmed-article:15078482pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:citationSubsetIMlld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15078482pubmed:statusMEDLINElld:pubmed
pubmed-article:15078482pubmed:monthAprlld:pubmed
pubmed-article:15078482pubmed:issn1478-3223lld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:HochmanAyalaAlld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:BruckRafaelRlld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:AeedHusseinHlld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:ScheyRonRlld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:PinesMarkMlld:pubmed
pubmed-article:15078482pubmed:authorpubmed-author:GeninaOlgaOlld:pubmed
pubmed-article:15078482pubmed:copyrightInfoCopyright Blackwell Munksgaard 2004lld:pubmed
pubmed-article:15078482pubmed:issnTypePrintlld:pubmed
pubmed-article:15078482pubmed:volume24lld:pubmed
pubmed-article:15078482pubmed:ownerNLMlld:pubmed
pubmed-article:15078482pubmed:authorsCompleteYlld:pubmed
pubmed-article:15078482pubmed:pagination169-76lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:meshHeadingpubmed-meshheading:15078482...lld:pubmed
pubmed-article:15078482pubmed:year2004lld:pubmed
pubmed-article:15078482pubmed:articleTitleA protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.lld:pubmed
pubmed-article:15078482pubmed:affiliationDepartment of Gastroenterology, The E. Wolfson Medical Center, Holon, Israel. rbruck@wolfson.health.gov.illld:pubmed
pubmed-article:15078482pubmed:publicationTypeJournal Articlelld:pubmed